These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12570 related articles for article (PubMed ID: 11848487)
1. Effects of interferon-beta in combination with 5-fluorouracil on the growth of esophageal cancer cells in vitro. Tsunoo H; Komura S; Ohishi N; Akiyama S; Kasai Y; Ito K; Nakao A; Yagi K Anticancer Res; 2001; 21(5):3301-6. PubMed ID: 11848487 [TBL] [Abstract][Full Text] [Related]
2. Effect of transfection with human interferon-beta gene entrapped in cationic multilamellar liposomes in combination with 5-fluorouracil on the growth of human esophageal cancer cells in vitro. Tsunoo H; Komura S; Ohishi N; Yajima H; Akiyama S; Kasai Y; Ito K; Nakao A; Yagi K Anticancer Res; 2002; 22(3):1537-43. PubMed ID: 12168834 [TBL] [Abstract][Full Text] [Related]
3. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo. Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649 [TBL] [Abstract][Full Text] [Related]
4. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent]. Ohmura K; Tsukamoto T Hinyokika Kiyo; 1989 May; 35(5):737-47. PubMed ID: 2801371 [TBL] [Abstract][Full Text] [Related]
5. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells. Guglielmi A; Aschele C; Mori A; Baldo C; Russo P; Debernardis D; Valenti M; Bruno S; Taverna M; Rosso R Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929 [TBL] [Abstract][Full Text] [Related]
6. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines. Bjelogrlić SK; Srdić T; Radulović S J BUON; 2007; 12(1):71-6. PubMed ID: 17436405 [TBL] [Abstract][Full Text] [Related]
7. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha. Oie S; Ono M; Yano H; Maruyama Y; Terada T; Yamada Y; Ueno T; Kojiro M; Hirano K; Kuwano M Int J Oncol; 2006 Dec; 29(6):1469-78. PubMed ID: 17088986 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells. De Filippi R; Prete SP; Giuliani A; Silvi E; Yamaue H; Nieroda CA; Greiner JW; De Vecchis L; Bonmassar E Anticancer Res; 1994; 14(5A):1767-73. PubMed ID: 7847809 [TBL] [Abstract][Full Text] [Related]
9. Combined effect of cisplatin and 5-fluorouracil with irradiation on tumor cells in vitro. Nagy B; Mucsi I; Molnár J; Thurzo L Anticancer Res; 2002; 22(1A):135-8. PubMed ID: 12017276 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment with insulin enhances anticancer functions of 5-fluorouracil in human esophageal and colonic cancer cells. Zou K; Ju JH; Xie H Acta Pharmacol Sin; 2007 May; 28(5):721-30. PubMed ID: 17439729 [TBL] [Abstract][Full Text] [Related]
11. [Experimental study of biochemical modulation of 5-fluorouracil with l-leucovorin against human esophageal cancer]. Terashima M; Ikeda K; Kawamura H; Maesawa C; Takiyama I; Yoshinari H; Koeda K; Sato N; Ishida K; Saito K Gan To Kagaku Ryoho; 1992 Oct; 19(12):1999-2004. PubMed ID: 1417007 [TBL] [Abstract][Full Text] [Related]
12. [Pathologic complete response of thoracic esophageal cancer developing after gastrectomy to neoadjuvant low-dose nedaplatin (CDGP), 5-fluorouracil and radiotherapy]. Takemura M; Osugi H; Lee S; Nishikawa T; Fukuhara K; Iwasaki H Gan To Kagaku Ryoho; 2005 Jul; 32(7):1023-7. PubMed ID: 16044966 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141 [TBL] [Abstract][Full Text] [Related]
14. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma. Nakamori M; Iwahashi M; Nakamura M; Yamaue H J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985 [TBL] [Abstract][Full Text] [Related]
15. New combination of 5-fluorouracil and interferon-gamma effective against human myeloid leukemia in vitro. Kafka M; Nathan I; Dvilansky A Anticancer Res; 1989; 9(4):1037-40. PubMed ID: 2510579 [TBL] [Abstract][Full Text] [Related]
16. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma. Ishii T; Marumo K Int J Urol; 2004 Nov; 11(11):993-1000. PubMed ID: 15509204 [TBL] [Abstract][Full Text] [Related]
17. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells. Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902 [TBL] [Abstract][Full Text] [Related]
19. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2. Jordan A; Stein J Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605 [TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo. Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]